While NT-proBNP and BNP biomarkers are currently employed to assess heart failure, particularly in emergency settings, to rule out cardiac cause of dyspnea [14], there is growing interest in their utility for AF diagnosis, especially in the context of stroke [16]. This evidence concerns the gene NPPB and stroke disorder.